Redditors can still rescue the stock down the line, but NAKD is not making the right strategic moves to ensure sustainable rallies. More
Articles
Xpeng Stock Could Soar on Its Expected Q3 Earnings Report
Third quarter results and the flying car news will work as catalysts for XPEV stock. It has ample upside in the coming months. More
Ready To Lead Alt-fuel Ecosystem, Plug Power Stock Can Double in a Year
Within a year, given excitement about the future of hydrogen, PLUG stock can trade at 15 times its 2025 sales estimate of $3 billion. More
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
NVAX stock's prospects in November depend upon regulatory developments regarding its Covid-19 vaccine candidate More
Novavax Stock Rises as UK Covid Vax Okay Sought, Other Growth Anticipated
Novavax stock offers a unique opportunity to invest in a late stage biotech built on cutting-edge vaccine technology, NVAX stock has surged on its Covid-19 vaccine potential, but don't forget its work on a universal vaccine for seasonal influenza. More
4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin
Ocuigen is unlikely to be able to get Covaxin widely distributed in the U.S. until Spring 2023. By that time, the shot won't help OCGN stock much if at all. More
DraftKings Has Monstrous Potential in the Future of Sports Betting
DraftKings is up for a solid quarter and is in a massive industry that's growing fast. DKNG stock will generate solid returns next year. More
